pharma · Primary Brain Tumor · Hepatocellular Carcinoma
Guerbet
Guerbet clinical programs — 4 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- VILLEPINTE, FR
- Founded
- 1926
- Employees
- 2,465
- Programs
- 4
- Drugs
- 5
- Patents
- 0
Guerbet projects
4 ClinicalTrials.gov programs sponsored by Guerbet.
Guerbet has 4 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
GDX-102/GDX-44-017
Guerbet
Suspected Vascular Disease of supra-aortic (carotid/vertebrobasilar), peripheral or abdominal/renal arteries
1 trial -
Dotarem®
Guerbet
Primary Brain Tumor
1 trial -
Gadoterate meglumine
Guerbet
Hepatocellular Carcinoma
1 trial -
Gadoxetate disodium
Guerbet
Motor Function
1 trial
Frequently asked questions
How many clinical projects does Guerbet have?
4 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.